相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT Within Patients with Gastroenteropancreatic Neuroendocrine Tumors
Damian Wild et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Quantification in 68Ga-DOTA(0)-Phe(1)-Tyr(3)-Octreotide Positron Emission Tomography/Computed Tomography: Can We Be Impartial about Partial Volume Effects?
Juri Ruf et al.
NEUROENDOCRINOLOGY (2013)
Comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-LAN PET/CT imaging in the same patient group with neuroendocrine tumours: preliminary results
Emre Demirci et al.
NUCLEAR MEDICINE COMMUNICATIONS (2013)
Biotherapies for GEP-NETs
Kjell Oberg
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2012)
Semiquantitative Analysis and Characterization of Physiological Biodistribution of 68Ga-DOTA-TATE PET/CT
Jolanta Kunikowska et al.
CLINICAL NUCLEAR MEDICINE (2012)
Feasibility and availability of 68Ga-labelled peptides
Clemens Decristoforo et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Treatment with Octreotide Does Not Reduce Tumor Uptake of 68Ga-DOTATATE as Measured by PET/CT in Patients with Neuroendocrine Tumors
Alexander R. Haug et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
68Ga-DOTA-NOC PET/CT Imaging of Neuroendocrine Tumors: Comparison with 111In-DTPA-Octreotide (OctreoScan®)
Yodphat Krausz et al.
MOLECULAR IMAGING AND BIOLOGY (2011)
The Impact of 68Ga-DOTATOC Positron Emission Tomography/Computed Tomography on the Multimodal Management of Patients With Neuroendocrine Tumors
Andrea Frilling et al.
ANNALS OF SURGERY (2010)
Immunohistochemical expression of somatostatin receptors in digestive endocrine tumours
V. Zamora et al.
DIGESTIVE AND LIVER DISEASE (2010)
Standardized Uptake Values of 68Ga-DOTANOC PET: A Promising Prognostic Tool in Neuroendocrine Tumors
Davide Campana et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors
Valentina Ambrosini et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
The Role of Ga-68-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on In-111-DTPA-Octreotide Scintigraphy
Rajaventhan Srirajaskanthan et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Quantification of immunohistochemical expression of somatostatin receptors in neuroendocrine tumors using 68Ga-DOTATATE PET/CT
A. R. Haug et al.
RADIOLOGE (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in Ga-68-DOTATOC PET/CT
Matthias Miederer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Bone Metastases in Patients with Neuroendocrine Tumor: 68Ga-DOTA-Tyr3-Octreotide PET in Comparison to CT and Bone Scintigraphy
Daniel Putzer et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Richard L. Wahl et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Functional Imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (Dota-DPhe1,Tyr3-octreotate) and 18F-FDG
Irfan Kayani et al.
CANCER (2008)
Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours
Valentina Ambrosini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: New prognostic factors for malignant well-differentiated endocrine tumors
Amani Asnacios et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Ga-68-DOTANOC: biodistribution and dosimetry in patients affected by neuroendocrine tumors
C. Pettinato et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Consensus guidelines for the management of patients with digestive neuroendocrine tumors - Well-differentiated jejunal-ileal tumor/carcinoma
Barbro Eriksson et al.
NEUROENDOCRINOLOGY (2008)
TNM staging of midgut and hindgut (neuro) endocrine tumors:: a consensus proposal including a grading system
G. Rindi et al.
VIRCHOWS ARCHIV (2007)
68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors:: Comparison with somatostatin receptor scintigraphy and CT
Michael Gabriel et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
The analysis of quantitative expression of somatostatin and dopamine receptors in gastro-entero-pancreatic tumours opens new therapeutic strategies
Dermot O'Toole et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
TNM staging of foregut (neuro)endocrine tumors:: a consensus proposal including a grading system
G. Rindi et al.
VIRCHOWS ARCHIV (2006)
Endocrine Tumors of the Ileum: Factors Correlated with Survival
Paola Tomassetti et al.
NEUROENDOCRINOLOGY (2006)
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization
F Panzuto et al.
ENDOCRINE-RELATED CANCER (2005)
Endocrine pancreatic tumors: factors correlated with survival
P Tomassetti et al.
ANNALS OF ONCOLOGY (2005)
Radiolabelling DOTA-peptides with 68Ga
WAP Breeman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases
P Hellman et al.
WORLD JOURNAL OF SURGERY (2002)
Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies
H Kulaksiz et al.
GUT (2002)
分享论文
